(R)-Hydroxy-O-ethyl Des(boric Acid) Bortezomib is an intermediate in the synthesis of (S)-Hydroperoxy Des(boric Acid) Bortezomib, which is an impurity of Bortezomib, the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. Molecular Formula: C21H28N4O3 Solubility: Chloroform, Dichloromethane, DMSO, Ethyl Acetate, Methanol Molecular Weight: 384.47 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
384.47
Formulierung:
Supplied as a White Solid
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
